Literature DB >> 16234973

Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways.

Farhan A Syed1, Ulrike I L Mödder, Daniel G Fraser, Thomas C Spelsberg, Clifford J Rosen, Andree Krust, Pierre Chambon, J Larry Jameson, Sundeep Khosla.   

Abstract

UNLABELLED: ER alpha acts either through classical (ERE-mediated) or nonclassical (non-ERE) pathways. The generation of mice carrying a mutation that eliminates classical ER alpha signaling presents a unique opportunity to study the relative roles of these pathways in bone. This study defines the skeletal phenotype and responses to ovariectomy and estrogen replacement in these mice.
INTRODUCTION: Estrogen receptor alpha (ER alpha) can act either through classical estrogen response elements (EREs) or through non-ERE (nonclassical) pathways. To unravel these in bone, we crossed mice heterozygous for a knock-in mutation abolishing ERE binding (nonclassical ER alpha knock-in [NERKI]) with heterozygote ER alpha knockout mice and studied the resulting female ER alpha(+/+), ER alpha(+/NERKI), and ER alpha(-/NERKI) mice. The only ER alpha present in ER alpha(-/NERKI) mice is incapable of activating EREs but can signal through nonclassical pathways, whereas ER alpha(+/NERKI) mice may have a less drastic alteration in the balance between classical and nonclassical estrogen signaling pathways.
MATERIALS AND METHODS: BMD was measured using DXA and pQCT at 3 months of age (n = 46-48/genotype). The mice were randomly assigned to sham surgery, ovariectomy, ovariectomy + estradiol (0.25 microg/day), or ovariectomy + estradiol (1.0 microg/day; n = 10-12/group) and restudied 60 days later. RESULTS AND
CONCLUSIONS: At 3 months of age, both the ER alpha(+/NERKI) and ER alpha(-/NERKI) mice had deficits in cortical, but not in trabecular, bone. Remarkably, changes in cortical bone after ovariectomy and estrogen replacement in ER alpha(-/NERKI) mice were the opposite of those in ER alpha(+/+) mice. Relative to sham mice, ovariectomized ER alpha(-/NERKI) mice gained more bone (not less, as in ER alpha(+/+) mice), and estrogen suppressed this increase (whereas augmenting it in ER alpha(+/+) mice). Estrogen also had opposite effects on bone formation and resorption parameters on endocortical surfaces in ER alpha(-/NERKI) versus ER alpha(+/+) mice. Collectively, these data show that alteration of the balance between classical and nonclassical ER alpha signaling pathways leads to deficits in cortical bone and also represent the first demonstration, in any tissue, that complete loss of classical ERE signaling can lead to paradoxical responses to estrogen. Our findings strongly support the hypothesis that there exists a balance between classical and nonclassical ER alpha signaling pathways, which, when altered, can result in a markedly aberrant response to estrogen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234973      PMCID: PMC1352155          DOI: 10.1359/JBMR.050713

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  33 in total

1.  Expression of estrogen receptor beta in rat bone.

Authors:  Y Onoe; C Miyaura; H Ohta; S Nozawa; T Suda
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT.

Authors:  S M Jorgensen; O Demirkaya; E L Ritman
Journal:  Am J Physiol       Date:  1998-09

3.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

Authors:  K Paech; P Webb; G G Kuiper; S Nilsson; J Gustafsson; P J Kushner; T S Scanlan
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

4.  Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.

Authors:  A Weisz; R Rosales
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

Review 5.  Steroid hormone receptors: many actors in search of a plot.

Authors:  M Beato; P Herrlich; G Schütz
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

Review 6.  Insights from the study of animals lacking functional estrogen receptor.

Authors:  K S Korach
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

7.  Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.

Authors:  Y Umayahara; R Kawamori; H Watada; E Imano; N Iwama; T Morishima; Y Yamasaki; Y Kajimoto; T Kamada
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

8.  Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor.

Authors:  A Ray; K E Prefontaine; P Ray
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

9.  Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice.

Authors:  Kathleen E McDougall; Mark J Perry; Rachel L Gibson; Shane M Colley; Kenneth S Korach; Jonathan H Tobias
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

10.  Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene.

Authors:  J F Savouret; A Bailly; M Misrahi; C Rauch; G Redeuilh; A Chauchereau; E Milgrom
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  32 in total

1.  The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.

Authors:  Carolyn D DuSell; Erik R Nelson; Xiaojuan Wang; Jennifer Abdo; Ulrike I Mödder; Michihisa Umetani; Diane Gesty-Palmer; Norman B Javitt; Sundeep Khosla; Donald P McDonnell
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Expression of an estrogen receptor agonist in differentiating osteoblast cultures.

Authors:  Thomas L McCarthy; Mary E Clough; Caren M Gundberg; Michael Centrella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

Review 3.  Estrogen and bones after menopause: a reappraisal of data and future perspectives.

Authors:  Panagiotis Anagnostis; Julia K Bosdou; Konstantina Vaitsi; Dimitrios G Goulis; Irene Lambrinoudaki
Journal:  Hormones (Athens)       Date:  2020-06-09       Impact factor: 2.885

4.  Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.

Authors:  Joshua D Stender; Kyuri Kim; Tze Howe Charn; Barry Komm; Ken C N Chang; W Lee Kraus; Christopher Benner; Christopher K Glass; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

5.  Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis.

Authors:  C Glidewell-Kenney; L A Hurley; L Pfaff; J Weiss; J E Levine; J L Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

6.  The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.

Authors:  Marta Martin-Millan; Maria Almeida; Elena Ambrogini; Li Han; Haibo Zhao; Robert S Weinstein; Robert L Jilka; Charles A O'Brien; Stavros C Manolagas
Journal:  Mol Endocrinol       Date:  2010-01-06

Review 7.  Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models.

Authors:  L Vico; J-M Vanacker
Journal:  Osteoporos Int       Date:  2009-06-03       Impact factor: 4.507

Review 8.  New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice.

Authors:  Melissa A McDevitt; Christine Glidewell-Kenney; Mariana A Jimenez; Patrick C Ahearn; Jeffrey Weiss; J Larry Jameson; Jon E Levine
Journal:  Mol Cell Endocrinol       Date:  2008-04-20       Impact factor: 4.102

9.  Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Authors:  Y Matsumoto; Y Mikuni-Takagaki; Y Kozai; K Miyagawa; K Naruse; H Wakao; R Kawamata; I Kashima; T Sakurai
Journal:  Osteoporos Int       Date:  2009-03-12       Impact factor: 4.507

Review 10.  Osteoarthritis associated with estrogen deficiency.

Authors:  Jorge A Roman-Blas; Santos Castañeda; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Arthritis Res Ther       Date:  2009-09-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.